Commonwealth Consolidated Regulations

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1960 - REG 37EH

         (1)   This regulation applies to a listed brand of a pharmaceutical item if:

                (a)    the brand is in:

                          (i)    the interim supplementary disclosure cycle; or

                         (ii)    a supplementary disclosure cycle B; and

               (b)    the data collection period in the disclosure cycle ends at the end of 31 May in a year.

         (2)   The brand moves to a main disclosure cycle on 1 June in the year.

         (3)   The data collection period for the brand in the main disclosure cycle:

                (a)    begins on 1 June in the year; and

               (b)    ends at the end of 30 September in the next year.